METHODS OF TREATING FIBROSING DISEASES BY INDUCTION OF IMMUNE TOLERANCE

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20140107035A1
SERIAL NO

14106038

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention has demonstrated for the first time that orally administered type I collagen (CI) induced tolerance to CI in patients suffering from systemic sclerosis (SSc) and ameliorated clinical manifestations of the disease. Accordingly, the present invention provides methods of treating a fibrosing disease by oral administration of a tissue protein, for example, collagen, derived from the tissue undergoing fibrosis.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
THE UNIVERSITY OF TENNESSEE RESEARCH FOUNDATIONKNOXVILLE TN 37996-4122

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Kang, Andrew H Memphis, US 7 27
Postlethwaite, Arnold E Eads, US 16 69

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation